However, the rapid sequencing and analysis of thousands upon thousands of human exomes and genomes has taught us that most genes, including those known to cause heritable cardiovascular disorders such as long QT syndrome, harbor an unexpected background rate of rare, and presumably innocuous, non-synonymous genetic variation.
A comparison between gene expression in velvet and skin samples from pedicle and frontal showed an opposite trend, with most genes, including BDNF, BMP2, FGF2, L1-CAM, Meteorin and NR-CAM, appearing downregulated in velvet.
Within the two subtypes, conservation of most genes, including the CARDS toxin gene and arginine deiminase genes, was observed.
Most genes, including GAPDH and ACTB, examined in this study were stable at early stages of differentiation (0.5 h or 6 h).
Transcripts were detected from the majority of candidates using DGE and qRT-PCR, suggesting that most genes, including those encoding the novel bZIPs, are not pseudogenes.
At fiber initiation and early elongation (0-8 DPA), most genes, including Exp, ManA2, Sus1, RacB, CelA3, CAP and RacA, had significantly higher expression levels in Hai7124 than in TM-1.
Moreover, antennal expression was confirmed for most genes included in the study.
Most genes included in module 3 encode chloroplast proteins such as 30S and 50S ribosomal proteins associated with protein biosynthesis in organelles, and chlorophyll biosynthesis related enzymes.
Most genes included solely in one of the strains were probably acquired by horizontal gene transfer due to differences in average % GC content between these genes and the harboring genomes.
Interestingly, the expression of most genes included within the "cell division" and "cell wall organization or biogenesis" categories peaked after 6 hAP in agreement with the timing of cell cycle re-activation in the cambium observed for this cultivar, as it is shown later.
Finally, most genes included in our panel are targeted by currently available drugs making them ideal candidates for genetic profiling however, with the exception of KRAS and EGFR, the full clinical implications of many of the mutations tested by our assay are still under investigation.
